Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer-Reference-Cited by-同舟云学术

Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer

Published:2005-10 Issue:1 Volume:77 Page:32-38
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Feng Mary,Jabbari Siavash,Lin Alexander,Bradford Carol R.,Chepeha Douglas B.,Teknos Theodoros N.,Worden Francis P.,Tsien Christina,Schipper Matthew J.,Wolf Gregory T.,Dawson Laura A.,Eisbruch Avraham

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference42 articles.

1. Extracapsular spread in the clinically negative neck: implications and outcome;Alvi;Otolaryngol Head Neck Surg,1996

2. Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers;Bastit;Int J Radiat Oncol Biol Phys,2001

3. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer;Bernier;NEJM,2004

4. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer;Bussels;Radiother Oncol,2004

5. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma;Calais;J Natl Cancer Inst,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoplasms of the Head and Neck;Holland‐Frei Cancer Medicine;2022-10-21

2. Kurative Radiochemotherapie von Kopf-Hals-Tumoren;TumorDiagnostik & Therapie;2022-03

3. Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy;Head & Neck;2022-02-25

4. Kurative Radiochemotherapie von Kopf-Hals-Tumoren;Laryngo-Rhino-Otologie;2021-01-27

5. An update on radiation therapy in head and neck cancers;Expert Review of Anticancer Therapy;2018-03